NR1H4 and metabolic dysfunction-associated steatohepatitis: In conclusion, chronic FXR activation with OCA is a potential strategy to inhibit cardiac inflammation, cardiac fibrosis, cardiac apoptosis, and cardiac hypocontractility, restore the cardiac regulatory T cell subset and function, and subsequently improve cardiac dysfunction in NASH mice.